228 related articles for article (PubMed ID: 34678117)
1. Host factors subverted by
Kalra R; Tiwari D; Dkhar HK; Bhagyaraj E; Kumar R; Bhardwaj A; Gupta P
Int Rev Immunol; 2023; 42(1):43-70. PubMed ID: 34678117
[TBL] [Abstract][Full Text] [Related]
2. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.
Zumla A; Rao M; Dodoo E; Maeurer M
BMC Med; 2016 Jun; 14():89. PubMed ID: 27301245
[TBL] [Abstract][Full Text] [Related]
3. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease.
Palucci I; Delogu G
Chemotherapy; 2018; 63(3):172-180. PubMed ID: 30032143
[TBL] [Abstract][Full Text] [Related]
4. Remembering the Host in Tuberculosis Drug Development.
Frank DJ; Horne DJ; Dutta NK; Shaku MT; Madensein R; Hawn TR; Steyn AJC; Karakousis PC; Kana BD; Meintjes G; Laughon B; Tanvir Z
J Infect Dis; 2019 Apr; 219(10):1518-1524. PubMed ID: 30590592
[TBL] [Abstract][Full Text] [Related]
5. Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment.
Kim YR; Yang CS
J Microbiol Biotechnol; 2017 Sep; 27(9):1549-1558. PubMed ID: 28683527
[TBL] [Abstract][Full Text] [Related]
6. Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis.
Ayodele S; Kumar P; van Eyk A; Choonara YE
Biomed Pharmacother; 2023 Jun; 162():114588. PubMed ID: 36989709
[TBL] [Abstract][Full Text] [Related]
7. Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches.
Mehta K; Spaink HP; Ottenhoff THM; van der Graaf PH; van Hasselt JGC
Trends Pharmacol Sci; 2022 Apr; 43(4):293-304. PubMed ID: 34916092
[TBL] [Abstract][Full Text] [Related]
8. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
Hawn TR; Shah JA; Kalman D
Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
[TBL] [Abstract][Full Text] [Related]
10. Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates.
Zumla A; Maeurer M;
Clin Infect Dis; 2015 Nov; 61(9):1432-8. PubMed ID: 26219693
[TBL] [Abstract][Full Text] [Related]
11. Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.
Rao M; Ippolito G; Mfinanga S; Ntoumi F; Yeboah-Manu D; Vilaplana C; Zumla A; Maeurer M
Int J Infect Dis; 2019 Mar; 80S():S62-S67. PubMed ID: 30685590
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
13. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
14. Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance.
Lohrasbi V; Talebi M; Bialvaei AZ; Fattorini L; Drancourt M; Heidary M; Darban-Sarokhalil D
Tuberculosis (Edinb); 2018 Mar; 109():17-27. PubMed ID: 29559117
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies.
Borah P; Deb PK; Venugopala KN; Al-Shar'i NA; Singh V; Deka S; Srivastava A; Tiwari V; Mailavaram RP
Curr Top Med Chem; 2021; 21(6):547-570. PubMed ID: 33319660
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.
Leukes V; Walzl G; du Plessis N
Front Immunol; 2020; 11():451. PubMed ID: 32269568
[TBL] [Abstract][Full Text] [Related]
17. Autophagy Induction as a Host-Directed Therapeutic Strategy against
Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
[TBL] [Abstract][Full Text] [Related]
18. Potential strategies for the management of drug-resistant tuberculosis.
Sharma D; Sharma S; Sharma J
J Glob Antimicrob Resist; 2020 Sep; 22():210-214. PubMed ID: 32169684
[TBL] [Abstract][Full Text] [Related]
19. Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs.
Baindara P; Agrawal S; Franco OL
Expert Rev Anti Infect Ther; 2022 Jun; 20(6):849-869. PubMed ID: 35188056
[TBL] [Abstract][Full Text] [Related]
20. Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches.
Al-Ghafli H; Al-Hajoj S
Curr Pharm Biotechnol; 2019; 20(4):272-284. PubMed ID: 30062961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
